Skip to main content

Solutex, N.A. LLC, Has Filed a Patent Infringement Lawsuit Against Designs for Health Inc.

The patent infringement relates to novel fish oil fractionates containing specialized pro-resolving mediators and their precursors.

WINSTON-SALEM, NC, October 08, 2020 /24-7PressRelease/ -- Solutex is a leading global manufacturer and supplier of highly concentrated omega-3 EPA/DHA fatty acids for pharmaceutical, nutritional and cosmetic industries; the Solutex Group is also the innovator of first to market LIPINOVA®, a proprietary ingredient containing standardized levels of SPMs and characterized resolution enhancing activity.

The above lawsuit resulted from the unauthorized use by Designs for Health of two important Solutex patents related to novel fish oil fractionates containing specialized pro-resolving mediators and their precursors.

Solutex's position as a leading global manufacturer is demonstrated by its significant investment in research and development and growing patent portfolio supporting the new market category the company has created. Solutex is clearly committed to defending and protecting its intellectual property and innovations.

The lawsuit, filed in the United States District Court in the Middle District of Florida (Case No. 3:20-cv-00800), seeks damages and an injunction that prevents Designs for Health from selling products that infringe Solutex's patents.

About Solutex

Solutex, a leader in the omega-3 industry, is uniquely positioned in the marketplace as a manufacturer of highly concentrated omega-3 EPA/DHA fatty acids, and execution of biolipid research and innovation critical to the development of next-generation formulas for the health and wellness industry. The development of Lipinova® is an innovation in immune-nutrition featuring Specialized ProResolving Mediators to support the body's natural capacity to resolve inflammation. Solutex is located in Europe with offices in Canada and the USA.

Find out more at http://www.SolutexCorp.com

---
Press release service and press release distribution provided by http://www.24-7pressrelease.com
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.